Compounds > paroxetine
Page last updated: 2024-08-23

paroxetine and Cardiometabolic Syndrome

paroxetine has been researched along with Cardiometabolic Syndrome in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
André, M; Aouizerate, B; Boyer, L; Capdevielle, D; Chereau, I; Coulon, N; Dassing, R; Dubertret, C; Etain, B; Fond, G; Godin, O; Leboyer, M; Leignier, S; Llorca, PM; Mallet, J; Misdrahi, D; Passerieux, C; Pignon, B; Rey, R; Schorr, B; Schürhoff, F; Szoke, A; Urbach, M1
Deuschle, M; Gilles, M; Henn, FA; Heuser, I; Kopf, D; Lederbogen, F; Lehnert, H; Luley, CW; Ritter, S; Weber-Hamann, B; Westphal, S1
Ben-Shushan, G; Gil-Ad, I; Hershkovitz, A; Isaac, R; Levkovitz, Y; Ronen, D; Shvartsman, D; Weizman, A; Zick, Y1

Other Studies

3 other study(ies) available for paroxetine and Cardiometabolic Syndrome

ArticleYear
3-year incidence and predictors of metabolic syndrome in schizophrenia in the national FACE-SZ cohort.
    Progress in neuro-psychopharmacology & biological psychiatry, 2023, 01-10, Volume: 120

    Topics: Adult; Antidepressive Agents; Female; Humans; Incidence; Lipids; Male; Metabolic Syndrome; Paroxetine; Prospective Studies; Risk Factors; Schizophrenia

2023
Lipid metabolism and insulin resistance in depressed patients: significance of weight, hypercortisolism, and antidepressant treatment.
    Journal of clinical psychopharmacology, 2004, Volume: 24, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Amitriptyline; Analysis of Variance; Antidepressive Agents; Blood Glucose; Body Mass Index; Cholesterol; Circadian Rhythm; Coronary Disease; Depressive Disorder, Major; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Insulin Resistance; Lipids; Lipoproteins; Male; Metabolic Syndrome; Middle Aged; Obesity; Paroxetine; Pituitary-Adrenal System; Risk Factors; Triglycerides

2004
Antidepressants induce cellular insulin resistance by activation of IRS-1 kinases.
    Molecular and cellular neurosciences, 2007, Volume: 36, Issue:3

    Topics: Animals; Cell Line, Tumor; Diabetes Mellitus; Enzyme Activation; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; JNK Mitogen-Activated Protein Kinases; Metabolic Syndrome; Paroxetine; Phosphoproteins; Phosphorylation; Protein Serine-Threonine Kinases; Rats; Selective Serotonin Reuptake Inhibitors; Serine; Sertraline; Signal Transduction

2007